Trials / Completed
CompletedNCT06374017
Evaluation of Lidocaine Spray Versus Dexmetomidine Spray on Stress Response
Evaluating the Effect of Topical Lidocaine Spray Versus Dexmedetomidine Spray on Suppression of Stress Response to Laryngoscopy and Endotracheal Intubation: a Randomized Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Many studies discussed attenuating stress response by various measures but to the interest of our study , No one compared topical spray of both lidocaine and dexmedetomidine in attenuating the haemodynamic stress responses of laryngoscopy and endotracheal intubation, avoiding undesired systemic effects of drugs ,
Detailed description
This study will be conducted in the operating theatres of Cairo university hospitals. Patients undergoing any surgery under general anesthesia and needs endotracheal intubation using direct laryngoscopy will be assigned to one of the three groups: Group C: will receive 5ml of normal saline sprayed via long nostril syringe into oropharynx, the vocal cords and tracheobronchial tree 5 minutes before intubation Group L: : will receive 5ml of lidocaine 2% (100mg) sprayed via long nostril syringe into oropharynx , the vocal cords and tracheobronchial tree 5 minutes before intubation Group D: : will receive dexmedetomidine (1 μg/kg) diluted in 5ml normal saline sprayed via long nostril syringe into oropharynx , the vocal cords and tracheobronchial tree 5 minutes before intubation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Normal saline, Lidocaine, dexmetomidine | The study drug of each group will be sprayed into oropharynx, the vocal cords and tracheal tree 3 minutes after induction of anesthesia and 5 minutes before intubation. |
Timeline
- Start date
- 2024-04-20
- Primary completion
- 2024-12-30
- Completion
- 2025-01-10
- First posted
- 2024-04-18
- Last updated
- 2025-04-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06374017. Inclusion in this directory is not an endorsement.